2023-02-02 |
NEDFHYDBTZ46130 |
RISING PHARMA HOLDINGS INC |
1808.0 kg |
300490
|
MEDICAMENTS, IN MEASURED DOSES, RETAIL PACKI G |
2023-01-30 |
SIFKSMUM102646 |
INGENUS PHARMACEUTICALS LLC |
8382.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP |
2023-01-27 |
SIFKSMUM102637 |
INGENUS PHARMACEUTICALS LLC |
7997.0 kg |
300490
|
PALLETSISOSORBIDE MONONITRATE EXTENDEDRELEASETABLETS USPHS CODE: 30049099HBL NO.SMUM10263 7SCAC CODE: SIFKFREIGHT COLLECT |
2023-01-07 |
BANQ1049920420 |
INGENUS PHARMACEUTICALS LLC |
8151.0 kg |
310510
|
TOTAL 40 WOODEN PALLETS ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 30MG (500 S COUNT) (39,187+500= 1,95,93,500 TABLETS - (587.8050 KG) BATCH NO.: UIDTA2069A UIDTA2070A UIDTA2071A UIDTA2072A UIDTA2073A UIDTA2074A UIDTA2076A UIDTA2077A UIDTA2078A UIDTA2075A MFG. DT:11 2022 EXP. DT:10 2025 INV NO: RA3690000012 DATE: 30-11-2022 BUYER S INDENT NO. 4500008317 DT: 14.03.2022 IEC NO: 0996000836 S BILL NO: 5860419 DATE: 01-12-2022 NET WT: 7350.6 KG GROSS WT: 8150.600 KG KGS |
2022-12-19 |
NEDFHYDBSK77152 |
RISING PHARMA HOLDINGS INC |
609.0 kg |
300490
|
MEDICAMENTS, IN MEASURED DOSES, RETAIL PACKI G |
2022-11-08 |
SIFKSMUM99376 |
INGENUS PHARMACEUTICALS LLC |
8009.0 kg |
300490
|
ISOSORBIDE MONONITRATEEXYENDED RELEASE TABLETSHS CODE: 30049099NAME A/C: 22-3876 BULLET 1 NAC RA CHEM PHARMA |
2022-10-27 |
SIFKSMUM99307 |
INGENUS PHARMACEUTICALS LLC |
7246.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS 60 MGISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS 30 MGNAMED ACCOUNT. |
2022-10-27 |
SIFKSMUM99306 |
INGENUS PHARMACEUTICALS LLC |
8596.0 kg |
310510
|
ISORBIDE MONONITRATE EXTENDEDRELEASE TABLETS 60MGNAMED ACCOUNTSVC: 22-3876 BULLET 1NAC RA CHEM PHARMA. |
2022-10-11 |
SIFKSMUM98915 |
INGENUS PHARMACEUTICALS LLC |
7056.0 kg |
310510
|
ISOORBIDE MONONITRATE EXTENDED-RELEASE TABLETS USP |
2022-10-02 |
HLCUBO12208AWUJ3 |
WDSRX WOODFIELD DISTRIBUTION LLC |
10182.0 kg |
300490
|
METHOCARBAMOL TABLETS USP 750MG TOTAL 15679 BOTTEL PACKED IN 40 WOODEN PALLETS METHOCARBAMOL TABLETS USP 750MG NDC NO.NDC 71093-141-05 ANDA NO 203550 INVOICE NO IN3600000088 DT 31-08-2022 IEC.NO 0996000836 SB.NO 3882663 DT 01-08-2022 HS CODE 30049099 NET WT 9381.540 KGS |
2022-09-09 |
SIFKSMUM96903 |
INGENUS PHARMACEUTICALS LLC |
3950.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 120MG |
2022-09-09 |
SIFKSMUM96904 |
INGENUS PHARMACEUTICALS LLC |
9048.0 kg |
310510
|
WOODENISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 30MGISOSORBIDE MONONITRATE EXTE NDEDRELEASE TABLETS USP, 60MG. |
2022-09-09 |
HLCUBO12207BJEZ0 |
WDSRX WOODFIELD DISTRIBUTION LLC |
8403.0 kg |
300490
|
METHOCARBAMOL TABLETS USP 750MG TOTAL 22660 BOTTEL PACKED IN 36 WOODEN PALLETS METHOCARBAMOL TABLETS USP 750MG (500S - COUNT) NDC NO.NDC 71093-141-05 METHOCARBAMOL TABLETS USP 750MG (500S - COUNT) NDC NO.NDC 71093-141-05 METHOCARBAMOL TABLETS USP 500MG (500S - COUNT) NDC NO.NDC 71093-140-05 METHOCARBAMOL TABLETS USP 500MG (100S - COUNT) NDC NO.NDC 71093-140-04 ANDA NO 203550 INVOICE NO 9100000074 DT 30-07-2022 IEC.NO 0996000836 SB.NO 3203175 DT 31-07-2022 HS CODE 30049099 NET WT 7682.740 KGS |
2022-08-28 |
SIFKSMUM96747 |
INGENUS PHARMACEUTICALS LLC |
8382.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 30MGISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 60MG. |
2022-08-22 |
NEDFHYDBMP21554 |
RISING PHARMA HOLDINGS INC |
590.0 kg |
300220
|
VACCINES FOR HUMAN MEDICINE |
2022-08-19 |
HLCUBO12207ARWS4 |
WDSRX WOODFIELD DISTRIBUTION LLC |
10193.0 kg |
300490
|
METHOCARBAMOL TABLETS USP TOTAL 15740 BOTTEL PACKED IN 40 WOODEN PALLETS METHOCARBAMOL TABLETS USP 750 MG (500S COUNT) NDC NO.NDC 71093-141-05 ANDA NO 203550 INVOICE NO 9100000026 DT 22-07-2022 IEC.NO 0996000836 SB.NO 3018769 DT 23-07-2022 HS CODE 30049099 NET WT 9392.55 KGS |
2022-08-09 |
HLCUBO12206AYXY0 |
RXCROSSROADS A/C ACI HEALTHCARE USA INC |
7383.0 kg |
300490
|
METHOCARBAMOL TABLETS US TOTAL 11675 BOTTLES PACKED IN 29 WOODEN PALLETS METHOCARBAMOL TABLETS USP 750 MG (500S COUNT) NDC NO.NDC 71093-141-05 METHOCARBAMOL TABLETS USP 750 MG (500S COUNT) NDC NO.NDC 71093-141-05 ANDA NO 203550 INVOICE NO RATG/22-23/187 DT 28-06-2022 IEC.NO 0996000836 SB.NO 2450482 DT 28-06-2022 HS CODE 30049099 NET WT 6802.630 KGS |
2022-08-04 |
HLCUBO12206AYVX8 |
RXCROSSROADS A/C ACI HEALTHCARE USA INC |
7535.0 kg |
310510
|
METHOCARBAMOL TABLETS USP 28 WOODEN PALLETS TOTAL 11592 BOTTEL PACKED IN 28 WOODEN PALLETS METHOCARBAMOL TABLETS USP 750 MG (500S COUNT) NDC NO.NDC 71093-141-05 ANDA NO 203550 INVOICE NO RATG/22-23/164 DT 21-06-2022 IEC.NO 0996000836 SB.NO 2291155 DT 22-05-2022 NET WT 6974.520 KGS |
2022-07-30 |
SIFKSMUM95594 |
INGENUS PHARMACEUTICALS LLC |
4524.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 60MGISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 120MG |
2022-07-30 |
SIFKSMUM95591 |
INGENUS PHARMACEUTICALS LLC |
4282.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 60MG |
2022-07-30 |
SIFKSMUM95593 |
INGENUS PHARMACEUTICALS LLC |
4089.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 60MG |
2022-07-24 |
SIFKSMUM95460 |
INGENUS PHARMACEUTICALS LLC |
4103.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP |
2022-07-24 |
SIFKSMUM95458 |
INGENUS PHARMACEUTICALS LLC |
4089.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, |
2022-07-17 |
SIFKSMUM94316 |
INGENUS PHARMACEUTICALS LLC |
4550.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 60MG |
2022-07-17 |
SIFKSMUM94313 |
INGENUS PHARMACEUTICALS LLC |
3864.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 30MGISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 120MG |
2022-07-17 |
SIFKSMUM94318 |
INGENUS PHARMACEUTICALS LLC |
4122.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 60MG ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 120MG |
2022-07-17 |
SIFKSMUM94317 |
INGENUS PHARMACEUTICALS LLC |
3847.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED-RELEASE TABLETS USP, 30MG |
2022-07-02 |
EXDO6650014505 |
AVET PHARMACEUTICAL INC |
3935.0 kg |
310510
|
VENLAFAXINE TABLETS |
2022-07-01 |
HLCUBO12205BVUK0 |
WDSRX WOODFIELD DISTRIBUTION LLC |
9028.0 kg |
300490
|
METHOCARBAMOL TABLETS USP TOTAL 33912 BOTTEL PACKED IN 41 WOODEN PALLETS METHOCARBAMOL TABLETS USP 500 MG (500S COUNT) NDC NO.NDC 71093-140-05 METHOCARBAMOL TABLETS USP 500 MG (100S COUNT) NDC NO.NDC 71093-140-04 METHOCARBAMOL TABLETS USP 750 MG (100S COUNT) NDC NO.NDC 71093-141-04 METHOCARBAMOL TABLETS USP 750 MG (500S COUNT) NDC NO.NDC 71093-141-05 ANDA NO 203550 INVOICE NO RATG/22-23/108 DT 30-05-2022 IEC.NO 0996000836 SB.NO 1780310 DT 31-05-2022 HS CODE 30049099 NET WEIGHT 8207.550 KGS |
2022-06-09 |
EXDO62C0201656 |
RISING PHARMA HOLDINGS INC |
596.0 kg |
310510
|
ZILEUTON ER TABLETS 600MG |
2022-05-31 |
SIFKSMUM93395 |
INGENUS PHARMACEUTICALS LLC |
3448.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 30MG (500 S COUNT)ADVANCE LICENSE NO: 0911001914(7,812 500 39,06,000 TABLETS (117 .1800 KG)ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 60MG (500 S COUNT) |
2022-05-31 |
SIFKSMUM93396 |
INGENUS PHARMACEUTICALS LLC |
3627.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 60MGREQUIRE GENSET AT DESTINATION. |
2022-05-31 |
SIFKSMUM93394 |
INGENUS PHARMACEUTICALS LLC |
4106.0 kg |
291229
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, ISOSORBIDE MONONITRATE EXTENDEDRELEASETABLETS USP, 30MG |
2022-05-31 |
SIFKSMUM92899 |
INGENUS PHARMACEUTICALS LLC |
4066.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 30MG (500 S COUNT) |
2022-05-27 |
EXDO6650014301 |
AVET PHARMACEUTICAL INC |
3176.0 kg |
310510
|
ACARABOSE TABLETS USP |
2022-05-12 |
WSPTMUM220003 |
KARTHA PHARMACEUTICALS |
4944.0 kg |
300490
|
BACLOFEN TABLETS RATG /21-22/984 DT 31/03/2022 HS CODE NO -30049099 BACLOFEN TABLETS RATG /21-22/984 DT 31/03/2022 HS CODE NO -30049099 |
2022-04-07 |
SIFKSMUM90102 |
INGENUS PHARMACEUTICALS LLC |
3847.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP |
2022-04-06 |
SIFKSMUM89896 |
INGENUS PHARMACEUTICALS LLC |
4076.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 30MGISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 60MG |
2022-04-06 |
SIFKSMUM89892 |
INGENUS PHARMACEUTICALS LLC |
3910.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 30MGISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, 60MG |
2022-04-06 |
SIFKSMUM89893 |
INGENUS PHARMACEUTICALS LLC |
4502.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 60MG |
2022-04-06 |
SIFKSMUM89895 |
INGENUS PHARMACEUTICALS LLC |
4144.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP, |
2022-03-28 |
SIFKSMUM89771 |
INGENUS PHARMACEUTICALS LLC |
4476.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP |
2022-03-23 |
SIFKSMUM90209 |
INGENUS PHARMACEUTICALS LLC |
3884.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS |
2022-03-18 |
EXDO62C0193892 |
RISING PHARMA HOLDINGS INC |
1189.0 kg |
310510
|
ZILEUTON ER TABLETS |
2022-03-08 |
SIFKSMUM88977 |
INGENUS PHARMACEUTICALS LLC |
3648.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS |
2022-03-08 |
SIFKSMUM88976 |
INGENUS PHARMACEUTICALS LLC |
3965.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP, 60MG |
2022-02-28 |
SIFKSMUM88996 |
INGENUS PHARMACEUTICALS LLC |
3923.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS |
2022-02-28 |
SIFKSMUM88998 |
INGENUS PHARMACEUTICALS LLC |
3928.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS |
2022-02-25 |
SIFKSMUM88371 |
INGENUS PHARMACEUTICALS LLC |
3850.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS USP |
2022-02-21 |
SIFKSMUM88372 |
INGENUS PHARMACEUTICALS LLC |
3888.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDEDRELEASE TABLETS USP |